Blog
Peptide Science North Carolina
Peptide Science North Carolina The Future of Medicine, Built in North Carolina: A Deep Dive into the State’s Peptide Science Revolution
Peptide Science North Carolina is quickly becoming an unsung powerhouse in the scientific field of peptides — short chains of amino acids that are revolutionizing drug discovery, manufacturing, and biotechnology. From world-class academic labs at institutions like UNC-Chapel Hill, Duke University, and NC State to a thriving commercial ecosystem in the Research Triangle Park (RTP), the state has emerged as a national leader in developing these versatile molecular tools.
- Academic Research Hubs Peptide Science North Carolina
North Carolina’s strength in peptide science is anchored by its leading research universities.
· UNC-Chapel Hill: At the Eshelman School of Pharmacy, Dr. Albert A. Bowers leads a lab focused on discovering peptide macrocycles as next-generation therapeutics, using mRNA display to rapidly synthesize and screen vast peptide libraries. Dr. Ronit Freeman combines peptides with DNA to build “living machines” — synthetic cells that deliver drugs and break down scar tissue, with potential treatments for lung disease and cognitive decline on the horizon.
· Duke University: Dr. Pranam Chatterjee and his team have developed PepPrCLIP, an AI platform that designs peptides capable of targeting proteins previously considered “undruggable” — a breakthrough that addresses more than 80% of disease-causing proteins that conventional therapies cannot reach.
· NC State University: Dr. Caroline Proulx focuses on designing peptide mimics that can fold and function with greater stability than natural peptides.
- Industrial & Commercial Landscape
Peptide Science North Carolina robust peptide industry stretches from academic startups to major CDMOs.
· ChromaGenix: An NC State spinoff that opened a 6,500-square-foot GMP facility in 2026 to manufacture synthetic peptide ligands for purifying advanced therapies, backed by a $35 million investment and a five-year plan to commercialize 10 new peptide-based technologies.
· Affinergy (RTP): Specializes in discovering peptides that “capture, deliver, and retain” specific targets, screening a library of 95 billion unique peptide sequences using phage display technology.
· Eldec Pharmaceuticals (Durham): Developing anti-inflammatory peptides to treat chronic lung disease.
· Onyx BioLabs (Charlotte) & Raybow USA (Brevard): Onyx BioLabs is a domestic leader in supplying high-purity research peptides, while Raybow USA provides integrated peptide API drug development and production.
· Alcami Corp. (Durham/RTP): Contract development and manufacturing organization (CDMO) with over 45 years of experience; has invested $6.7 million to acquire a 37,000-square-foot facility in RTP and added 20,000 square feet of lab space to boost analytical capacity for peptide-based therapies and advanced biologics.
- Economic & Research Impact
Peptide Science North Carolina sector is a significant economic driver. The 20,000-square-foot expansion at Alcami supports hundreds of specialized jobs, while ChromaGenix is expected to create more than 40 jobs at its new facility. A robust network of shared resources — including the UNC High-Throughput Peptide Synthesis Core Facility, which provides specialized services for modifying and characterizing synthetic peptides — lowers barriers to entry for new companies and academic researchers alike.
- The Future of Peptide Science in North Carolina
The state is pushing the boundaries of what peptides can achieve:
· AI-Driven Discovery: Duke’s PepPrCLIP platform generated peptides that successfully bound to beta-catenin, a disordered cancer-driving protein, opening doors to therapies for previously untreatable cancers.
· Advanced Manufacturing: NC State’s ChromaGenix is developing novel peptide ligands for purifying gene therapies, making advanced treatments more affordable and scalable.
· Sustainable Materials: Dr. Ronit Freeman’s lab is engineering peptide-based biodegradable plastics that dissolve after their intended function, tackling the global plastic waste crisis.
Conclusion
Peptide Science North Carolina landscape has reached a critical mass, fueled by visionary academic research, strategic industry investment, and a collaborative ecosystem that bridges discovery and commercialization. From AI-designed peptide therapeutics to sustainable biomaterials, the Tar Heel State is building the molecular foundation for a healthier and more sustainable future.